Gregory Conko | Publications

Lost lives the real costs of regulator overreach

By Henry I. Miller, Gregory Conko,
May 4, 2013

Ignore Hysteria Over New ‘Monsanto’ Bill

By Gregory Conko,
April 8, 2013

FTC Drug Meddling Would Needlessly Push Pharmaceutical Costs Higher

By Gregory Conko,
March 24, 2013

GMO Labeling to Appear on Washington Ballot

By Gregory Conko,
January 30, 2013

21 Limited-Government Organizations Agree: House Should Repeal Dangerous IPAB

By Gregory Conko,
January 28, 2013

The Ripple Effects of Flawed Agbiotech Regulation

By Gregory Conko, Henry I. Miller,
January 9, 2013

Free Speech for Big Pharma

By Henry I. Miller, Gregory Conko,
November 14, 2012

A Losing Proposition on Food Labeling

By Gregory Conko, Henry I. Miller,
October 11, 2012

"Genetically Engineered" In California: A Food Label We Don't Need

By Gregory Conko, Henry I. Miller,
October 8, 2012

Is There a Future for Generic Biotech Crops?

By Gregory Conko,
September 25, 2012

Labeling Of Genetically Engineered Foods Is A Losing Proposition

By Henry I. Miller, Gregory Conko,
September 12, 2012

Mass. biotech reaps Monsanto deal

By Gregory Conko,
August 30, 2012

FDA rules won't do much good

By Gregory Conko, Ryan Young,
August 23, 2012

High Price of Cheap Drug Imports

By Gregory Conko,
May 18, 2012

Critical Drug Shortages Reaching Crisis

By Gregory Conko,
April 11, 2012

Mayo v. Prometheus and Diagnostic Patents: What Does the Supreme Court Decision Really Mean?

By Gregory Conko,
April 4, 2012

The Anti-GM Food Circus Rolls Through Connecticut

By Gregory Conko,
February 24, 2012

Shoppers already have a choice regarding biotech foods

By Gregory Conko,
February 17, 2012

Seeking Solution to "Incredibly Complex" Issue of Drug Shortages

By Gregory Conko,
February 7, 2012

Can Brand Makers Be Sued for Generic Drug Injuries?

By Gregory Conko,
January 30, 2012